Searching for a possible clinicopathological relevance of the observed negative regulation of caspase-7, the data from the Xena platform [41] showed a significant decrease in caspase-7 mRNA expression levels in the primary tumor tissue from CRC patients when compared to normal adjacent tissue. The gene discussed is CASP7; the disease is colorectal carcinoma.